Bird & Bird advised Fonds Patient Autonome and Uniqa Ventures on their €4 million financing round of Fizimed

International law firm Bird & Bird advised Fonds Patient Autonome, managed by Bpifrance, and Uniqa Ventures on their participation in the €4 million financing round of Fizimed, a femtech dedicated to women's health.

The Fonds Patient Autonome and Uniqa Ventures led the financing round, in which UI Investissement also participated.

The Bird & Bird team advising Fonds Patient Autonome and Uniqa Ventures comprised of partner Carole Bodin and associate Pascaline Sagot, who advised on the corporate aspects, with partner Alexandre Vuchot and associate Caroline Arrighi-Savoie advising on the regulatory aspects.

The company was advised by Charles Russell Speechlys. The team comprised of partner Renaud Ferry and Counsel Orlando Vignoli Neto.

News & Deals

More News & Deals
Deal Bird & Bird advises Ciclad on acquiring a majority stake in Capelec Group

Oct 22 2025

Read More
News Bird & Bird Sponsors Slush for Fourth Consecutive Year

Oct 20 2025

Read More
Deal Bird & Bird advises FUJIFILM Healthcare on acquisition of endoscopy business

Oct 16 2025

Read More
Deal Bird & Bird advises Integrated Eduverse on Sale of SUN Education to StudyIn

Oct 16 2025

Read More
Deal Bird & Bird advises Obton A/S on financing the development costs of 72 photovoltaic farms in Poland

Oct 14 2025

Read More
Deal Bird & Bird advises Serwent on strategic acquisition of Röranalys i Sverige AB and ISAB Rörinfodring AB

Oct 10 2025

Read More